摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-Butoxy-phenyl)-acetic acid | 143895-99-2

中文名称
——
中文别名
——
英文名称
(2-Butoxy-phenyl)-acetic acid
英文别名
(2-Butoxyphenyl)acetic acid;2-(2-butoxyphenyl)acetic acid
(2-Butoxy-phenyl)-acetic acid化学式
CAS
143895-99-2
化学式
C12H16O3
mdl
MFCD06653493
分子量
208.257
InChiKey
GDVFKEUCAFZRKK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (2-Butoxy-phenyl)-acetic acid氯化亚砜 作用下, 生成 2-(2-butoxyphenyl)acetyl chloride
    参考文献:
    名称:
    取代的 4-氨基-1,3,5-三芳基-1H-吡咯-2(5H)-酮的合成
    摘要:
     抽象的 通过用芳基乙酰氯酰化 α-芳基氨基腈并随后在氢氧化钾存在下进行分子内环化,合成了 4-氨基-1,3,5-三芳基-1H-吡咯-2(5H)-酮的新衍生物。类似地,1-烯丙基-4-氨基-3,5-二苯基-1,5-二氢-2H-吡咯-2-酮由2-(烯丙基氨基)-2-苯基乙腈与β-乙烯键形成。 2-苯基-1-(2-苯乙酰基)吡咯烷-2-甲腈是通过2-(3-氯丙氨基)-2-苯基乙腈与苯乙酰氯的酰化和随后的分子内环化合成的。在氢氧化钾存在下,N-(3-氯丙基)-N-(氰基(苯基)甲基-2-苯基乙酰胺发生分子内环化时,反应进行时同时闭合第二个环并形成双环产品 – 1-氨基-2,7a-二苯基-5,6,7,7a-四氢-3H-吡咯嗪-3-酮。
    DOI:
    10.1134/s1070363224050037
点击查看最新优质反应信息

文献信息

  • [EN] INSECTICIDAL DIAZOLE AND TRIAZOLE DERIVATIVES<br/>[FR] DERIVES DE DIAZOLE ET DE TRIAZOLE INSECTICIDES
    申请人:FMC CORP
    公开号:WO2005108374A1
    公开(公告)日:2005-11-17
    It has now been found that certain novel diazole and triazole derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I). Preferred are those compounds of formula (I) where M and Q are carbon; R is methyl; R1 and R2 taken together are -CH=CHCH=CH-, -C(Cl)=CHCH=CH-, -C(F)=CHCH=CH-, or -C(CH3)=CHCH=CH-; X is straight or branched chain alkylenyl; Y is phenyl; and R4 is one or more hydrogen, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, cyano, amino, or -(O)t-(CH2)v-Z-R6, where Z is -C(R7)=C(R8)-, -C≡C-, or -C(R7)=NO-; and, R6, R7 and R8 are indepdently hydrogen, halogen, or alky. In addition, compositions comprising an insecticidally effective amount of at least one compound of formula (I), and optionally, an effective amount of at least one of a second compound, with at least one insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to the locus of crops where insects are present or are expected to be present.
    已经发现了某些新型二唑和三唑衍生物具有意想不到的杀虫活性。这些化合物由式(I)表示。首选的是式(I)中M和Q为碳;R为甲基;R1和R2一起取-CH=CHCH=CH-, -C(Cl)=CHCH=CH-, -C(F)=CHCH=CH-或-C(CH3)=CHCH=CH-;X为直链或支链烷基;Y为苯基;R4为一个或多个氢、卤素、烷基、卤代烷基、烷氧基、卤代烷氧基、基、基或-(O)t-(CH2)v-Z-R6,其中Z为-C(R7)=C(R8)-,-C≡C-或-C(R7)=NO-;而R6、R7和R8独立地为氢、卤素或烷基。此外,还公开了包含至少一种式(I)化合物的杀虫有效量和可选地至少一种第二化合物的有效量,以及至少一种杀虫载体的组合物;以及涉及将这些组合物施用于存在或预计存在昆虫的作物生长地点以控制昆虫的方法。
  • [EN] USE OF DERIVATIVES OF 2, 4-DIHYDRO-[1,2,4]TRIAZOLE-3-THIONE AS INHIBITORS O FTEH ENZYME MYELOPEROXIDASE (MPO)<br/>[FR] UTILISATION DE DERIVES DE 2, 4-DIHYDRO-[1,2,4]TRIAZOLE-3-THIONES COMME INHIBITEURS DE L'ENZYME MYELOPEROXYDASE (MPO)
    申请人:ASTRAZENECA AB
    公开号:WO2004096781A1
    公开(公告)日:2004-11-11
    There is disclosed the use of a compound of formula (I) wherein X, Y, W and Q are as defined in the specification, and pharmaceutically acceptable salts thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of the enzyme myeloperoxidase (MPO) is beneficial. Certain novel compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed, together with processes for their preparation. The compounds of formulae (I) are MPO inhibitors and are thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders.
    揭示了使用公式(I)中X、Y、W和Q如规范中定义的化合物及其药用盐,在制造药物中用于治疗或预防对髓过氧化物酶(MPO)抑制有益的疾病或症状。公开了某些公式(I)的新化合物及其药用盐,以及它们的制备方法。公式(I)的化合物是MPO抑制剂,因此在治疗或预防神经炎症性疾病中特别有用。
  • Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
    申请人:Svensson Mats
    公开号:US20070093483A1
    公开(公告)日:2007-04-26
    There is disclosed the use of a compound of formula (I) wherein X, Y, W and Q are as defined in the specification, and pharmaceutically acceptable salts thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of the enzyme myeloperoxidase (MPO) is beneficial. Certain novel compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed, together with processes for their preparation. The compounds of formulae (I) are MPO inhibitors and are thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders.
    本发明揭示了使用化合物(I)的使用,其中X、Y、W和Q如规范中所定义,以及其药学上可接受的盐,在制造药物方面,用于治疗或预防抑制髓过氧化物酶(MPO)酶有益的疾病或状况。揭示了某些新型化合物(I)及其药学上可接受的盐,以及其制备方法。化合物(I)的MPO抑制剂,因此特别适用于治疗或预防神经炎症性疾病。
  • PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY
    申请人:Cannizzaro Carina
    公开号:US20090227543A1
    公开(公告)日:2009-09-10
    The invention is related to phosphonate substituted compounds having immuno-modulatory activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及磷酸酯取代化合物,具有免疫调节活性,含有这种化合物的组合物,以及包括这种化合物的给药的治疗方法,还涉及用于制备这种化合物的有用过程和中间体。
  • ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS
    申请人:Cannizzaro Carina
    公开号:US20090247488A1
    公开(公告)日:2009-10-01
    The invention is related to phosphorus substituted anti-inflammatory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    本发明涉及取代的抗炎化合物、含有这种化合物的组合物、包括给药这种化合物的治疗方法,以及用于制备这种化合物的有用过程和中间体。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯